Atlas Trials

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

Clinical trial NCT02401269 · COMPLETED

Trial details

NCT number
NCT02401269
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cardiovascular Disease Risk in HIV PatientsEndothelial Function
Start date
2015-04-01
Primary completion
2016-01-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.